Krystal Biotech, Inc. (KRYS)
253.69
-6.64
(-2.55%)
USD |
NASDAQ |
Mar 06, 16:00
253.76
+0.07
(+0.03%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (TTM) : 146.91M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| DexCom, Inc. | 1.291B |
| Scholar Rock Holding Corp. | 131.18M |
| Alkermes Plc | 701.52M |
| Stoke Therapeutics, Inc. | 58.79M |